VitaNova Life Sciences (VNOV) Cash from Investing Activities (2017)
VitaNova Life Sciences (VNOV) reported Cash from Investing Activities of -$16538.0 for Q4 2017.
VitaNova Life Sciences (VNOV) Cash from Investing Activities (2017) Analysis & Trends
VitaNova Life Sciences has reported Cash from Investing Activities for 1 years, with the latest figure at -$16538.0 in Q4 2017.
- For the quarter ending Q4 2017, Cash from Investing Activities changed N/A year-over-year to -$16538.0; the trailing twelve-month figure through Jan 2020 stood at -$16538.0 (changed N/A YoY), and the FY2018 full-year result was -$33914.0, changed N/A from the prior year.
- Cash from Investing Activities for Q4 2017 stood at -$16538.0.
- The five-year high for Cash from Investing Activities was -$16538.0 in Q4 2017, with the low at -$16538.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 425.00 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -4.87 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -181.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -63.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 53.93 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -754,000.00 |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -3.21 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -708,963.00 |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2017 | -16,538.00 |
| Oct 31, 2017 | -16,538.00 |